Delivery Order SPE2DP20D0002-SPE2DP20F5515
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 contract has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva has previously received similar delivery orders from the Defense Logistics Agency to support military immunization programs. The company also holds active indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Teva with DLA Troop Support Medical for providing critical pharmaceuticals to support military immunization programs. Teva has also been awarded other significant...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $146,823.93 order is not set aside and has a completion date of July 26, 2022. Teva has previously received numerous delivery orders from the Defense Logistics Agency to supply adenovirus vaccines and other pharmaceutical products such as albuterol inhalers to federal...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747.00 award has an October 27, 2020 completion date and was issued on October 19, 2020. This delivery order supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple indefinite delivery contracts with federal agencies, including a 5-year IDIQ with the...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide Adenovirus Type 4 vaccine. The $135,747.00 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva has received numerous awards from the Defense Logistics Agency and Department of Veterans Affairs to supply vaccines, antiviral medications, respiratory...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm fixed-price delivery order to provide Adenovirus Type 4 vaccine. This order was not set aside under any special socioeconomic program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has an extensive history of providing drug products, including vaccines and respiratory medications, to federal agencies such as the Department of Defense...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP20F5515Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $271,494.00 award has a completion date of June 23, 2020 and was issued on June 17, 2020. Teva is an experienced government contractor, having received numerous delivery orders from DLA Troop Support Medical to supply adenovirus vaccines in support of military immunization programs. The company also holds active indefinite delivery contracts with the Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons to furnish a variety of pharmaceutical products including inhalers and respiratory treatments.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $271.5k | 6/17/20 |